Changhua, Taiwan

Hung-chih Chen

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Academia Sinica. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hung-chih Chen. Retrieved from https://idiyas.com/inventor/hung-chih-chen-gnfoc3fh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Hung-chih Chen

Introduction

Hung-chih Chen is a notable inventor based in Changhua, Taiwan. He has made significant contributions to the field of drug delivery systems, particularly in enhancing the efficacy of treatments for cancer. His innovative approach has garnered attention in the scientific community.

Latest Patents

Hung-chih Chen holds a patent titled "Monocyte-Specific Aptamers and Uses Thereof for Enhancing Drug Delivery to Cancer." This patent represents a breakthrough in targeted drug delivery, utilizing specific aptamers to improve the effectiveness of cancer therapies. He has 1 patent to his name, showcasing his commitment to advancing medical technology.

Career Highlights

Chen is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in his field. His dedication to research and innovation has positioned him as a key figure in cancer treatment advancements.

Collaborations

Some of his notable coworkers include Kengjung Lee and Patrick CH Hsieh. Their collaborative efforts have further enhanced the research output and innovation at Academia Sinica.

Conclusion

Hung-chih Chen's contributions to drug delivery systems exemplify the impact of innovative thinking in the medical field. His work continues to inspire future advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…